TBRG
TruBridge, Inc.22.25
-0.27-1.2%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Retention drag lingers into 2026
Q&A largely reaffirmed prepared remarks on pipeline strength and margin gains, but added nuance that 2025 retention attrition carries modestly into 2026, supporting only flat-to-modest improvement and modest revenue growth. Management detailed a homegrown AI pilot for early claims denial prediction, in early innings sans KPIs, targeting the 15% denial rate. No bookings capacity constraints, just customer timing; more margin room beyond 200 bps via AI efficiencies and encoder mix. Strategic review timeline? None. Retention fixes and pipeline conversion matter next.
Key Stats
Market Cap
334.01MP/E (TTM)
92.71Basic EPS (TTM)
0.24Dividend Yield
0%Recent Filings
8-K
Q4 results; profit turnaround
TruBridge posted Q4 revenue of $87.2M, down slightly from $88.1M, yet swung to full-year GAAP net income of $4.4M from a $20.9M loss. Bookings hit $19.8M in Q4 and $82.9M yearly, with recurring revenue at 94%; Adjusted EBITDA climbed to $68.7M. Strategic review underway—no deal assured. Immaterial prior-period revisions corrected revenue timing.
10-K
FY2025 results
TruBridge posted FY2025 revenues of $346.8M, up 1% y/y, with Financial Health at $221.7M (up 2%) driving the gain via new bookings despite attrition, while Patient Care held flat at $125.2M amid Centriq sunsetting. Q4 momentum built on full-year trends, as recurring revenues hit $327.2M (94% of total) and margins expanded via offshore labor shifts and cost cuts, lifting operating income to $20.8M from $6.4M. Cash from operations jumped to $37.0M. Debt stands at $166.6M with $82.5M revolver capacity. Strategic review weighs alternatives. Hospital consolidations threaten the client base.
8-K
Appoints Pinetree's Leonard to board
TruBridge signed a cooperation agreement with largest shareholder Pinetree Capital on January 7, 2026, expanding its board from nine to ten to appoint Damien Leonard effective January 12. Leonard joins the Compensation Committee; three long-serving directors exit by 2027, shrinking board to seven post-2026 meeting. Pinetree commits to standstill and board-aligned voting. Board refreshment advances.
8-K
TruBridge refinances, ups facilities
TruBridge amended its credit agreement on November 25, 2025, boosting revolver capacity from $160M to $180M while hiking the term loan from $54M to $70M—total facilities now $250M through 2030. Pricing tiers down to SOFR+1.75% at leverage below 1.50x; covenants cap leverage at 3.75x initially. Lenders expanded—Regions leads with Bank of America, Fifth Third, Synovus, Trustmark, Bryant, Flagstar. More liquidity, yet higher debt load.
10-Q
Q3 FY2025 results
TruBridge posted Q3 revenues of $86.1M, up 2% y/y, with Financial Health steady at $54.5M and Patient Care rising 5% to $31.6M on SaaS growth despite Centriq sunset. Operating income climbed to $4.1M from $2.8M y/y, boosted by cost cuts in both segments; diluted EPS swung to $0.37 from -$0.61, reconciled to 14,527K shares. YTD, revenues hit $259.0M (+2% y/y), operating income $15.9M (derived), net income $8.6M, OCF $28.1M, and FCF $15.6M (derived, capex $12.5M). Cash swelled to $19.9M, revolver availability $48.6M, total debt $165.2M due 2027; sold building for $0.3M. OBBBA tax benefits aided Q3. Medicaid cuts loom large.
IPO
Website
Employees
Sector
Industry
BTSG
BrightSpring Health Services, I
36.44+0.48
CCLD
CareCloud, Inc.
3.21+0.02
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
CTEV
Claritev Corporation
38.35+0.39
DH
Definitive Healthcare Corp.
2.29-0.01
GEHC
GE HealthCare Technologies Inc.
82.25-2.20
HCAT
Health Catalyst, Inc
2.44+0.09
PHLT
Performant Healthcare, Inc.
7.75+0.00
PHR
Phreesia, Inc.
16.35-0.35
PRVA
Privia Health Group, Inc.
23.81-0.53